Alnylam Pharmaceuticals, Inc. (ALNY) Misses Q4 EPS by 6c
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q4 EPS of ($0.51) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
